Zacks de estoque aeri
AERI: Aerie Pharmaceuticals, Inc. - Earnings Announcements. Stay up to date with lastest Earnings Announcements for Aerie Pharmaceuticals, Inc. from Zacks Investment Research by Zacks Equity Research Published on March 13,2019 . Aerie (AERI) gets FDA approval for Rocklatan to reduce elevated IOP in patients with open-angle glaucoma or ocular hypertension and announces its 2019 revenue and cash burn outlook. PFE CELG BDSI AERI. pharmaceuticals